Description
Nitib 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.
Nitib 140mg Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects.
Nitib 140mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Nitib 140mg Capsule is a Bruton’s tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Nitib 140mg Capsule should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Nitib 140mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Nitib 140mg Capsule may be needed. Please consult your doctor.
Chronic lymphocytic leukemia (CLL) is a slow-growing blood cancer in which the bone marrow makes abnormal white blood cells that crowd out healthy cells and weaken the immune system. Nitib 140mg Capsule helps block signals that cancer cells need to grow and multiply, slowing disease progression and supporting healthier blood cell balance. This helps manage symptoms, maintain immune function, and improve quality of life.
Reviews
There are no reviews yet.